WT
HQL

Washington Trust’s abrdn Life Sciences Investors HQL Stock Holding History

Washington Trust’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10
Closed -$148 – 867
2024
Q3 		$148 Buy
+10
New +$151 ﹤0.01% 842
2020
Q2 		– Sell
-289
Closed -$4K – 926
2020
Q1 		$4K Buy
+289
New +$4.73K ﹤0.01% 774
2018
Q3 		– Sell
-1,050
Closed -$20K – 491
2018
Q2 		$20K Buy
+1,050
New +$19.8K ﹤0.01% 578

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Washington Trust's HQL Position: Q4 2024 in Review

Washington Trust sold out of abrdn Life Sciences Investors (HQL) in Q4 2024, closing a stake of 10 shares — an estimated $148 sold.

Washington Trust first reported a position in HQL in Q2 2018 and held it in 3 quarters. The position peaked at $20K in Q2 2018. 72 funds tracked by Wall St. Rank hold HQL as of Q4 2024.

  • Washington Trust reported no remaining abrdn Life Sciences Investors position as of Q4 2024 after selling out during the quarter.
  • Washington Trust sold 10 abrdn Life Sciences Investors shares in Q4 2024, an estimated $148.
  • Washington Trust first reported a position in abrdn Life Sciences Investors in Q2 2018 and held it in 3 quarters.
  • Washington Trust's abrdn Life Sciences Investors position peaked at $20K in Q2 2018.
  • 72 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2024.

Based on Washington Trust's 13F filing for Q4 2024, filed 30 Jan 2025.